Penn spinout Verismo Therapeutics raises $17M in second pre-Series A round

Verismo Therapeutics will use the funds to advance its experimental immunotherapies targeting solid tumors and blood cancers.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 18, 2023 Category: Pharmaceuticals Authors: John George Source Type: news